About ReNu® ReNu is a cryopreserved, amniotic suspension allograft developed for the management of symptomatic knee osteoarthritis. ReNu consists of amniotic fluid cells and micronized amniotic ...

Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of product ...

Popular Latter-day Saint apostle Jeffrey R. Holland, known for his powerful and poetic sermons, has died at age 85 from ...

The launch of island-wide special customs operations at South China's Hainan Free Trade Port represents a major strategic ...

NIS2 is in effect and the to-do list for CISOs is exploding. The frequent result: unclear requirements, a huge documentation ...

Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...

Recently, Beijing Economic-Technological Development Area (Beijing E-Town) issued the "Several Measures on Accelerating the Cultivation of the Future Energy Industry." Focusing on clean energy sectors ...

YARTEMLEA is approved by the U.S. FDA for the treatment of TA-TMA in adults and in children ages two years and older. A marketing authorization application for YARTEMLEA for TA-TMA is under review by ...

KEY POINTS One of the longest-duration pumped storage hydropower projects in the country is proposed for Navajo Nation land in the Four Corners region. The project received a $7.1 million Department ...

The Supreme Court deliberated for weeks over the Trump administration’s claim that National Guard troops were necessary to ...

Explore the top 7 API automation testing tools for software developers in 2025, their features, strengths, pricing, and how they enhance API reliability and performance.

About Profound Medical Corp. Profound is a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue.